Literature DB >> 2964956

Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.

D Montagna1, R Maccario, A G Ugazio, G Mingrat, G R Burgio.   

Abstract

In 28 healthy full-term newborns the percentage of circulating cells expressing the Leu7 antigen, the marker of natural killer (NK) cells, was significantly lower than in healthy adults. However, newborns and adults did not differ with regard to the percentage of cells reacting with the Leulla, Leullc and TEC NK-1, monoclonal antibodies directed against the IgG Fc receptor of killer cells. Spontaneous NK activity of neonatal cells was profoundly reduced compared to the adult. In contrast, antibody dependent cellular cytotoxicity and NK-like activity generated in mixed lymphocyte cultures were similar in the two groups and lymphokine-activated killer cell (LAK) activity was high in the neonate. Natural killing is thought to play an important role in antiviral immunity since the neonate has a deficient capacity to deal with viral infections. Consequently, the present data indicate either that spontaneous NK is the most informative in vitro measure of newborn natural cytotoxicity in vivo, or, alternatively, that natural killing is not as important in antiviral immunity as previously suggested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964956      PMCID: PMC1541643     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Distinction of anti-K562 and anti-allocytotoxicity in in vitro-stimulated populations of human lymphocytes.

Authors:  A Poros; E Klein
Journal:  Cell Immunol       Date:  1979-08       Impact factor: 4.868

2.  Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities.

Authors:  J K Seeley; S H Golub
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

3.  T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells.

Authors:  L Moretta; D Pende; R Cozzani; A Merli; M Bagnasco; M C Mingari
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

4.  Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.

Authors:  M López-Botet; A Silva; J Rodríguez; M O de Landazuri
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

5.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures.

Authors:  M G Masucci; E Klein; S Argov
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

7.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

Authors:  H Rabin; R F Hopkins; F W Ruscetti; R H Neubauer; R L Brown; T G Kawakami
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity.

Authors:  J R Ortaldo; G D Bonnard; P D Kind; R B Herberman
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

9.  Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody.

Authors:  T Abo; M D Cooper; C M Balch
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  4 in total

1.  A variant of the Nijmegen breakage syndrome with unusual cytogenetic features and intermediate cellular radiosensitivity.

Authors:  R Tupler; G L Marseglia; M Stefanini; E Prosperi; L Chessa; T Nardo; A Marchi; P Maraschio
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation.

Authors:  P Comoli; R Maccario; D Montagna; M Labirio; M Zecca; R Clementi; F Bonetti; F Locatelli
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

3.  Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.

Authors:  C M Gardiner; D J Reen
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

4.  Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood.

Authors:  Seok-Gu Kang; Chung Hun Ryu; Sin Soo Jeun; Chun Kun Park; Hyung-Jin Shin; Jong Hyun Kim; Moon Chan Kim; Joon Ki Kang
Journal:  Childs Nerv Syst       Date:  2004-02-13       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.